these studies suggest a potential beneficial pharmacological role for igsrk in the treatment of disorders characterized by pathogenic autoantibodies , but also warn of a potential deleterious effect of inhibiting the host 's humoral response to an infectious challenge .
C0012634
disorders
C0009450
infectious